MedTrace Logo

Transfusion of Whole Blood to Military Forces in a Combat Situation

NCT04496700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-08-03

No results posted yet for this study

Summary

During military action there might be situations where civil requirements for blood transfusion are not obtainable. Numerous warfare experiences suggest that administration of whole blood to a patient with uncontrollable bleeding/bleeding shock will improve survival in case of delayed evacuation.

Among Norwegian troops this gives one of two choices:

1. A soldier donates blood to a wounded fellow soldier
2. Personnel in safe distance donates blood and it is transported to the frontline.

Alternative b might implicate frequent donations and unused blood must be auto-re-transfused.

This study will investigate:

1. Can 'buddy transfusion' in the field be justified also in medical aspects?
2. Can repeated donations and auto-transfusions of transported whole blood into personnel(X) be justified also in medical aspects?

(X) Blood typed and screened for HIV, HBV, HCV, Syphilis before assignment

Conditions

  • Autologous Blood Transfusion
  • Physical Performance
  • Donor Safety

Interventions

PROCEDURE

Whole blood donation and transfusion

The effect of whole blood donation on physical performance: Donation of 450 ml whole blood - one time only.

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Geir Strandenes, OF3 · Haukeland UH

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04496700 on ClinicalTrials.gov